Author

Ashwin N. Ananthakrishnan 1

1 Massachusetts General Hospital and Harvard Medical School,Boston,Unite

A UNITED STATES CLAIMS DATABASE ANALYSIS COMPARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASS

Gráinne H. Long, Amanda R. Tatro, Young S. Oh, Sheila Reiss Reddy, Ashwin N. Ananthakrishnan

EVALUATION OF OZANIMOD EFFICACY AND SAFETY IN OLDER PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE PHASE 3 TRUE NORTH STUDY

Peter Irving, Ashwin N. Ananthakrishnan, Irina Blumenstein, Sara Horst, HARRIS AHMAD, Garrett Lawlor, Vanessa Hobbs, Anjali Jain, Arteid Memaj, Nabeel Khan

Exome-wide sequencing study of Primary Sclerosing Cholangitis - a two population study

Jukka Koskela, Michiel Voskuil, Manuel A Rivas, Brandon Avila, Christine Stevens, Samuli Ripatti, Ramnik J. Xavier, Ashwin N. Ananthakrishnan, Harry Sokol, Rinse K. Weersma, Mark J. Daly, Martti A. Färkkila

How to deal with refractory or relapsing Clostridium difficile colitis

Ashwin N. Ananthakrishnan

Item 1 - 4 / 5
1